Shell Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $370K | Sell |
3,756
-1,519
| -29% | -$151K | 0.04% | 388 |
|
|
2025
Q2 | $481K | Buy |
5,275
+2,790
| +112% | +$270K | 0.02% | 502 |
|
|
2025
Q1 | $281K | Hold |
2,485
| – | – | 0.01% | 647 |
|
|
2024
Q4 | $262K | Hold |
2,485
| – | – | 0.01% | 727 |
|
|
2024
Q3 | $268K | Buy |
+2,485
| New | +$271K | 0.01% | 728 |
|
|
2024
Q1 | $270K | Sell |
2,485
-2,040
| -45% | -$255K | 0.01% | 712 |
|
|
2023
Q4 | $551K | Buy |
+4,525
| New | +$505K | 0.03% | 483 |
|
|
2021
Q3 | – | Sell |
-797
| Closed | -$124K | – | 1506 |
|
|
2021
Q2 | $124K | Sell |
797
-897
| -53% | -$145K | ﹤0.01% | 1328 |
|
|
2021
Q1 | $263K | Sell |
1,694
-441
| -21% | -$68.3K | 0.01% | 1073 |
|
|
2020
Q4 | $319K | Buy |
2,135
+537
| +34% | +$75.8K | 0.01% | 979 |
|
|
2020
Q3 | $211K | Sell |
1,598
-374
| -19% | -$48.9K | ﹤0.01% | 1027 |
|
|
2020
Q2 | $229K | Sell |
1,972
-5,212
| -73% | -$601K | 0.01% | 990 |
|
|
2020
Q1 | $705K | Sell |
7,184
-515
| -7% | -$67.5K | 0.02% | 530 |
|
|
2019
Q4 | $1.12M | Sell |
7,699
-5,611
| -42% | -$775K | 0.02% | 508 |
|
|
2019
Q3 | $1.77M | Sell |
13,310
-468
| -3% | -$60.5K | 0.04% | 368 |
|
|
2019
Q2 | $1.57M | Sell |
13,778
-17,367
| -56% | -$2.03M | 0.03% | 412 |
|
|
2019
Q1 | $3.86M | Buy |
31,145
+17,183
| +123% | +$1.95M | 0.09% | 255 |
|
|
2018
Q4 | $1.41M | Sell |
13,962
-1,312
| -9% | -$148K | 0.04% | 402 |
|
|
2018
Q3 | $1.95M | Sell |
15,274
-1,577
| -9% | -$188K | 0.04% | 396 |
|
|
2018
Q2 | $1.82M | Buy |
16,851
+1,158
| +7% | +$126K | 0.04% | 422 |
|
|
2018
Q1 | $1.66M | Buy |
15,693
+206
| +1% | +$23.9K | 0.03% | 450 |
|
|
2017
Q4 | $1.81M | Buy |
15,487
+4,822
| +45% | +$545K | 0.04% | 417 |
|
|
2017
Q3 | $1.21M | Sell |
10,665
-13,188
| -55% | -$1.52M | 0.03% | 527 |
|
|
2017
Q2 | $2.97M | Sell |
23,853
-626
| -3% | -$74.2K | 0.06% | 304 |
|
|
2017
Q1 | $2.9M | Buy |
24,479
+2,519
| +11% | +$286K | 0.06% | 301 |
|
|
2016
Q4 | $2.2M | Sell |
21,960
-26,151
| -54% | -$2.8M | 0.05% | 366 |
|
|
2016
Q3 | $6.07M | Sell |
48,111
-1,594
| -3% | -$197K | 0.13% | 203 |
|
|
2016
Q2 | $5.81M | Sell |
49,705
-3,544
| -7% | -$401K | 0.13% | 176 |
|
|
2016
Q1 | $5.51M | Buy |
53,249
+23,276
| +78% | +$2.25M | 0.13% | 171 |
|
|
2015
Q4 | $2.98M | Sell |
29,973
-8,506
| -22% | -$832K | 0.07% | 274 |
|
|
2015
Q3 | $3.76M | Buy |
38,479
+9,492
| +33% | +$952K | 0.06% | 278 |
|
|
2015
Q2 | $3.07M | Sell |
28,987
-4,461
| -13% | -$494K | 0.06% | 308 |
|
|
2015
Q1 | $3.82M | Sell |
33,448
-8,157
| -20% | -$931K | 0.07% | 280 |
|
|
2014
Q4 | $4.58M | Buy |
41,605
+3,126
| +8% | +$330K | 0.07% | 261 |
|
|
2014
Q3 | $3.76M | Sell |
38,479
-25,933
| -40% | -$2.55M | 0.06% | 288 |
|
|
2014
Q2 | $6.5M | Buy |
64,412
+34,163
| +113% | +$3.33M | 0.1% | 194 |
|
|
2014
Q1 | $2.78M | Sell |
30,249
-279
| -0.9% | -$25.7K | 0.05% | 371 |
|
|
2013
Q4 | $2.76M | Sell |
30,528
-10,782
| -26% | -$933K | 0.05% | 376 |
|
|
2013
Q3 | $3.29M | Sell |
41,310
-4,985
| -11% | -$392K | 0.06% | 335 |
|
|
2013
Q2 | $3.37M | Buy |
+46,295
| New | +$3.46M | 0.06% | 307 |
|
Other funds holding ZBH
Shell Asset Management's ZBH Position: Q3 2025 in Review
Shell Asset Management reduced its Zimmer Biomet (ZBH) stake by 29% in Q3 2025, selling an estimated $151K and leaving 3,756 shares worth $370K. The position accounts for 0.04% of the portfolio, ranked #388.
Shell Asset Management first reported a position in ZBH in Q2 2013 and has held it in 40 quarters since. The position peaked at $6.5M in Q2 2014. 967 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Shell Asset Management held 3,756 shares of Zimmer Biomet worth $370K as of Q3 2025.
- Shell Asset Management sold 1,519 Zimmer Biomet shares in Q3 2025, an estimated $151K.
- Zimmer Biomet made up 0.04% of Shell Asset Management's portfolio in Q3 2025, its #388 holding.
- Shell Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 40 quarters since.
- Shell Asset Management's Zimmer Biomet position peaked at $6.5M in Q2 2014.
- 967 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.